| Financial Year |
March 31 2023 |
| Monetary Funds |
2,725,906,866.43 |
| Held-for-trading Financial Assets |
2,055,246,017.87 |
| Notes Receivable |
219,062,215.00 |
| Accounts Receivable |
1,027,133,242.36 |
| Advances to Suppliers |
156,370,494.69 |
| Other Receivables |
34,454,244.81 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
8,444,377.47 |
| Dividend Receivable |
-- |
| Inventories |
1,352,015,529.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
81,373,024.01 |
| Total Current Assets |
7,702,963,531.16 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
1,069,804.00 |
| Long-term Equity Investment |
478,016,221.33 |
| Investment Properties |
86,331,199.06 |
| Fixed Assetes |
57,432,904.14 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
5,501,190.68 |
| R&D expenses |
2,004,289.11 |
| Goodwill |
391,622,255.42 |
| Long-Term Deferred and Prepaid Expenses |
9,236,680.88 |
| Deferred Income Tax Assets |
257,683,720.16 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
1,713,954,532.23 |
| Total Assets |
9,416,918,063.39 |
| Short-Term Loans |
715,421,055.56 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
638,405,775.93 |
| Accounts Received In Advance |
15,295,015.46 |
| Employee Compensation Payable |
43,103,925.68 |
| Taxes Payable |
93,973,646.70 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
92,721,647.80 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
12,609,876.22 |
| Other Current Liabilities |
61,340,666.33 |
| Sub-Total of Current Liabilities |
2,281,796,575.48 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
15,879,483.27 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
78,008,984.34 |
| Total Liabilities |
2,359,805,559.82 |
| Paid-In Capital(Or Share Stock) |
1,901,073,701.00 |
| Capital Surplus |
3,530,298,486.35 |
| Surplus Reserve |
140,818,504.96 |
| LESS:Treasury Stock |
180,410,507.21 |
| Undistributed Profits |
1,941,177,825.48 |
| Minority Stockholder's Interest |
134,781,329.94 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,922,331,173.63 |
| Owner's Equity（Stockholder's Equity） |
7,057,112,503.57 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
9,416,918,063.39 |
